Published in Proc Natl Acad Sci U S A on January 01, 1987
Foot-and-mouth disease. Clin Microbiol Rev (2004) 4.34
The structure and evolution of the major capsid protein of a large, lipid-containing DNA virus. Proc Natl Acad Sci U S A (2002) 3.07
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Poliovirus cell entry: common structural themes in viral cell entry pathways. Annu Rev Microbiol (2002) 2.93
Conserved sequence features of inteins (protein introns) and their use in identifying new inteins and related proteins. Protein Sci (1994) 2.54
A second proteinase encoded by a plant potyvirus genome. EMBO J (1989) 2.44
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol (1993) 2.39
Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol (1990) 2.25
Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J (1989) 2.24
Cleavage site analysis in picornaviral polyproteins: discovering cellular targets by neural networks. Protein Sci (1996) 2.12
Capsid protein VP4 of poliovirus is N-myristoylated. Proc Natl Acad Sci U S A (1987) 2.12
Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro. J Virol (1988) 2.09
Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci (1994) 2.06
A viral cleavage site cassette: identification of amino acid sequences required for tobacco etch virus polyprotein processing. Proc Natl Acad Sci U S A (1988) 2.00
Viral cell recognition and entry. Protein Sci (1994) 1.93
Biochemical and mutational analysis of a plant virus polyprotein cleavage site. EMBO J (1988) 1.91
Three poliovirus 2B mutants exhibit noncomplementable defects in viral RNA amplification and display dosage-dependent dominance over wild-type poliovirus. J Virol (1991) 1.84
Translation of polioviral mRNA is inhibited by cleavage of polypyrimidine tract-binding proteins executed by polioviral 3C(pro). J Virol (2002) 1.77
Proteolytic processing of foot-and-mouth disease virus polyproteins expressed in a cell-free system from clone-derived transcripts. J Virol (1987) 1.77
Potential secondary and tertiary structure in the genomic RNA of foot and mouth disease virus. Nucleic Acids Res (1987) 1.62
Processing determinants required for in vitro cleavage of the poliovirus P1 precursor to capsid proteins. J Virol (1987) 1.61
Picornaviruses. Curr Top Microbiol Immunol (2010) 1.53
Temperature-sensitive poliovirus mutant fails to cleave VP0 and accumulates provirions. J Virol (1990) 1.48
Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu 1 are required for site-specific cleavage to mu 1C in transfected cells. J Virol (1992) 1.44
Seneca Valley Virus 3Cpro Substrate Optimization Yields Efficient Substrates for Use in Peptide-Prodrug Therapy. PLoS One (2015) 1.42
Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol (1990) 1.41
The curious case of protein splicing: mechanistic insights suggested by protein semisynthesis. Protein Sci (1993) 1.40
Cleavage of small peptides in vitro by human rhinovirus 14 3C protease expressed in Escherichia coli. J Virol (1989) 1.38
Association of heat shock protein 70 with enterovirus capsid precursor P1 in infected human cells. J Virol (1992) 1.38
Proteolytic cleavage of encephalomyocarditis virus capsid region substrates by precursors to the 3C enzyme. J Virol (1989) 1.38
Structures of the procapsid and mature virion of enterovirus 71 strain 1095. J Virol (2013) 1.32
Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids. J Virol (1995) 1.27
Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures. J Virol (1991) 1.26
Acid-induced structural changes in human rhinovirus 14: possible role in uncoating. Proc Natl Acad Sci U S A (1992) 1.25
Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles. J Virol (1992) 1.25
Catalysis of poliovirus VP0 maturation cleavage is not mediated by serine 10 of VP2. J Virol (1991) 1.25
Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP. J Virol (1993) 1.18
Role of sialyloligosaccharide binding in Theiler's virus persistence. J Virol (1997) 1.16
Site-specific mutations at a picornavirus VP3/VP1 cleavage site disrupt in vitro processing and assembly of capsid precursors. J Virol (1987) 1.15
Complementation of a poliovirus defective genome by a recombinant vaccinia virus which provides poliovirus P1 capsid precursor in trans. J Virol (1993) 1.15
Poliovirus mutants at histidine 195 of VP2 do not cleave VP0 into VP2 and VP4. J Virol (1999) 1.14
Purification and partial characterization of poliovirus protease 2A by means of a functional assay. J Virol (1988) 1.13
Degradation of cellular proteins during poliovirus infection: studies by two-dimensional gel electrophoresis. J Virol (1989) 1.09
Molecular epidemiology of coxsackievirus A16: intratype and prevalent intertype recombination identified. PLoS One (2013) 1.08
A rapid method for determination of endoproteinase substrate specificity: specificity of the 3C proteinase from hepatitis A virus. Proc Natl Acad Sci U S A (1991) 1.07
Postsecretory modifications of streptavidin. Biochem J (1989) 1.03
Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. J Virol (1995) 1.02
Characterization of synthetic foot-and-mouth disease virus provirions separates acid-mediated disassembly from infectivity. J Virol (1997) 1.01
Expression, purification and characterization of enterovirus-71 virus-like particles. World J Gastroenterol (2006) 0.97
A mutant poliovirus containing a novel proteolytic cleavage site in VP3 is altered in viral maturation. J Virol (1990) 0.96
Expanding knowledge of P3 proteins in the poliovirus lifecycle. Future Microbiol (2010) 0.90
Molecular classification of enteroviruses not identified by neutralization tests. Emerg Infect Dis (2002) 0.89
Picornavirus morphogenesis. Microbiol Mol Biol Rev (2014) 0.88
SUMOylation promotes PML degradation during encephalomyocarditis virus infection. J Virol (2010) 0.87
The Structure of Human Parechovirus 1 Reveals an Association of the RNA Genome with the Capsid. J Virol (2015) 0.86
Mutagenesis of the coxsackie B3 virus 2B/2C cleavage site: determinants of processing efficiency and effects on viral replication. J Virol (1996) 0.84
Cell-Free Protein Synthesis: Pros and Cons of Prokaryotic and Eukaryotic Systems. Chembiochem (2015) 0.81
Challenge models to assess new therapies in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2012) 0.81
Poliovirus capsid proteins derived from P1 precursors with glutamine-valine cleavage sites have defects in assembly and RNA encapsidation. J Virol (1993) 0.81
Identification of active-site residues in protease 3C of hepatitis A virus by site-directed mutagenesis. J Virol (1997) 0.81
NMR structure of a viral peptide inserted in artificial membranes: a view on the early steps of the birnavirus entry process. J Biol Chem (2010) 0.79
Inducible expression of encephalomyocarditis virus 3C protease activity in stably transformed mouse cell lines. J Virol (1989) 0.78
Human rhinovirus 2A proteinase mutant and its second-site revertants. Biochem J (1996) 0.78
Chimeric rhinoviruses obtained via genetic engineering or artificially induced recombination are viable only if the polyprotein coding sequence derives from the same species. J Virol (2015) 0.77
Peptide-lipid interactions: experiments and applications. Int J Mol Sci (2013) 0.77
Application of the phase extension method in virus crystallography. Crystallogr Rev (2015) 0.75
Parvovirus capsid structures required for infection: mutations controlling receptor recognition and protease cleavages. J Virol (2016) 0.75
Both cis and trans Activities of Foot-and-Mouth Disease Virus 3D Polymerase Are Essential for Viral RNA Replication. J Virol (2016) 0.75
Coxsackieviral replication and pathogenicity: lessons from gene modified animal models. Med Microbiol Immunol (2003) 0.75
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
Morphogenesis of poliovirus. I. Association of the viral RNA with coat protein. J Mol Biol (1968) 6.58
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. Nucleic Acids Res (1984) 4.95
The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res (1984) 3.85
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Translation of encephalomyocarditis virus RNA in reticulocyte lysates: kinetic analysis of the formation of virion proteins and a protein required for processing. J Virol (1979) 3.64
Molecular cloning and complete sequence determination of RNA genome of human rhinovirus type 14. Proc Natl Acad Sci U S A (1985) 3.17
Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J Virol (1982) 3.03
Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99
Picornaviral structure and assembly. Microbiol Rev (1981) 2.93
Kinetics of synthesis and cleavage of encephalomyocarditis virus-specific proteins. Virology (1972) 2.54
Primary structure and gene organization of human hepatitis A virus. Proc Natl Acad Sci U S A (1985) 2.43
Expression of a cloned gene segment of poliovirus in E. coli: evidence for autocatalytic production of the viral proteinase. Cell (1984) 2.29
Correlation between sites of limited proteolysis and segmental mobility in thermolysin. Biochemistry (1986) 1.80
Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature (1981) 1.73
In vitro synthesis and assembly of picornaviral capsid intermediate structures. J Virol (1982) 1.56
Comparison of the structures of carboxypeptidase A and thermolysin. J Biol Chem (1977) 1.46
Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology (1982) 1.44
Similarities in active center geometries of zinc-containing enzymes, proteases and dehydrogenases. J Mol Biol (1978) 1.40
Encephalomyocarditis virus-specific polypeptide p22 is involved in the processing of the viral precursor polypeptides. FEBS Lett (1979) 1.39
Aspects of biochemical catalysis. Cell (1984) 1.26
Morphogenesis of poliovirus 3. Formation of provirion in cell-free extracts. J Virol (1973) 1.20
Encephalomyocarditis virus-specific polypeptide p22 possessing a proteolytic activity: preliminary mapping on the viral genome. FEBS Lett (1979) 1.14
Picornaviral capsid assembly: similarity of rhinovirus and enterovirus precursor subunits. J Virol (1977) 1.11
The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin. Cold Spring Harb Symp Quant Biol (1972) 1.08
Structure of the Mengo virion. II. Physicochemical and electron microscopic analysis of degraded virus. Virology (1974) 1.04
Radiochemical determination of polyamines in poliovirus and human rhinovirus 14. J Biol Chem (1984) 0.96
Structure of porcine pancreatic prephospholipase A2. Nature (1976) 0.96
Errors in protein structures. Nature (1996) 18.70
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Structure of a human common cold virus and functional relationship to other picornaviruses. Nature (1985) 12.90
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
Chemical and biological evolution of nucleotide-binding protein. Nature (1974) 7.39
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol (1989) 7.01
Viral proteinases. Annu Rev Biochem (1988) 6.76
Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev (1990) 6.64
X-ray crystallographic structure of the Norwalk virus capsid. Science (1999) 6.58
The separation of soluble ribonucleic acids on benzoylated diethylaminoethylcellulose. Biochemistry (1967) 6.04
Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures. Proteins (1996) 5.83
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50
Polyadenylic acid at the 3'-terminus of poliovirus RNA. Proc Natl Acad Sci U S A (1972) 5.42
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
Structure of the bacteriophage phi29 DNA packaging motor. Nature (2000) 5.25
Cell-free, de novo synthesis of poliovirus. Science (1991) 5.09
The nucleotide and deduced amino acid sequences of the encephalomyocarditis viral polyprotein coding region. Nucleic Acids Res (1984) 4.95
Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell (1999) 4.87
Comparison of super-secondary structures in proteins. J Mol Biol (1973) 4.85
A database of protein structure families with common folding motifs. Protein Sci (1992) 4.77
A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A (1993) 4.71
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides. Proc Natl Acad Sci U S A (1995) 4.37
Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA. EMBO J (2001) 4.36
The atomic structure of Mengo virus at 3.0 A resolution. Science (1987) 4.34
Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (1991) 4.24
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
Rotation function calculations with GLRF program. Methods Enzymol (1997) 3.99
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
GPCRDB: an information system for G protein-coupled receptors. Nucleic Acids Res (1998) 3.94
Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol (1996) 3.93
The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol (1994) 3.85
Defective interfering particles of poliovirus. I. Isolation and physical properties. J Virol (1971) 3.74
Determining the intensity of Bragg reflections from oscillation photographs. Methods Enzymol (1985) 3.72
Protease required for processing picornaviral coat protein resides in the viral replicase gene. J Virol (1979) 3.70
Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66
Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature (1998) 3.64
Structure of a human rhinovirus complexed with its receptor molecule. Proc Natl Acad Sci U S A (1993) 3.62
Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62
Conserved role of a complement-like protein in phagocytosis revealed by dsRNA knockout in cultured cells of the mosquito, Anopheles gambiae. Cell (2001) 3.58
Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58
Interaction of poliovirus polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding. J Biol Chem (1994) 3.45
New POU dimer configuration mediates antagonistic control of an osteopontin preimplantation enhancer by Oct-4 and Sox-2. Genes Dev (1998) 3.43
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature (1983) 3.35
Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides. Virology (1983) 3.28
Sequence and structural elements that contribute to efficient encephalomyocarditis virus RNA translation. J Virol (1992) 3.28
Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol (1986) 3.15
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution. J Mol Biol (1998) 3.14
Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol (2000) 3.14
A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell (1982) 3.07
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Lamivudine (3TC) resistance in HIV-1 reverse transcriptase involves steric hindrance with beta-branched amino acids. Proc Natl Acad Sci U S A (1999) 3.03
Evidence for intramolecular self-cleavage of picornaviral replicase precursors. J Virol (1982) 3.03
Optimizing the hydrogen-bond network in Poisson-Boltzmann equation-based pK(a) calculations. Proteins (2001) 3.03
Genome-linked proteins of viruses. Cell (1982) 3.02
Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Selective excision of AZTMP by drug-resistant human immunodeficiency virus reverse transcriptase. J Virol (2001) 2.95
PRODRG, a program for generating molecular topologies and unique molecular descriptors from coordinates of small molecules. J Comput Aided Mol Des (1996) 2.94
Assembly of a tailed bacterial virus and its genome release studied in three dimensions. Cell (1998) 2.91
Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing. Proc Natl Acad Sci U S A (1981) 2.91
Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein. J Virol (1991) 2.86
The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology (2001) 2.83
Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A (1996) 2.78
The structure of coxsackievirus B3 at 3.5 A resolution. Structure (1995) 2.73
Encephalomyocarditis virus 3C protease: efficient cell-free expression from clones which link viral 5' noncoding sequences to the P3 region. J Virol (1986) 2.72
Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A (1996) 2.71
Structure of unliganded HIV-1 reverse transcriptase at 2.7 A resolution: implications of conformational changes for polymerization and inhibition mechanisms. Structure (1996) 2.69
The locked rotation function. Acta Crystallogr A (1990) 2.65
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol (1982) 2.63
Conformational change in the floor of the human rhinovirus canyon blocks adsorption to HeLa cell receptors. J Virol (1989) 2.61